Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
International Journal of Molecular Sciences
|
April 26, 2019
High Body Mass Index is Associated with Elevated Blood Levels of Progerin mRNA
Moritz Messner, Santhosh Kumar Ghadge, Thomas Schuetz, et al.
Plos One
|
April 28, 2018
Upregulation of the aging related LMNA splice variant progerin in dilated cardiomyopathy
Moritz Messner, Santhosh Kumar Ghadge, Valentina Goetsch, et al.
Aging
|
January 12, 2022
Endothelial and systemic upregulation of miR-34a-5p fine-tunes senescence in progeria
Christina Manakanatas, Santhosh Kumar Ghadge, Azra Agic, et al.
Cells
|
September 3, 2020
ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA
Moritz Messner, Santhosh Kumar Ghadge, Thomas Maurer, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
May 28, 2017
Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair
Santhosh Kumar Ghadge, Moritz Messner, Thi Van Pham, et al.
International Journal of Cardiology
|
June 23, 2009
Plasma HER2 levels are not associated with cardiac function or hypertrophy in control subjects and heart failure patients
Maximilian G Posch, Anna Panek, Andrea Kersten, et al.
Cells
|
July 12, 2024
Roxadustat Attenuates Adverse Remodeling Following Myocardial Infarction in Mice
Marc-Michael Zaruba, Simon Staggl, Santhosh Kumar Ghadge, et al.
The Lancet. Infectious Diseases
|
April 28, 2025
Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trial
Laura Wagner, Michaela Obersriebnig, Vera Kadlecek, et al.
The Lancet. Infectious Diseases
|
July 19, 2024
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial
Santhosh Kumar Ghadge, Martina Schneider, Katrin Dubischar, et al.
International Journal of Molecular Sciences
|
June 2, 2021
Smooth Muscle Specific Ablation of CXCL12 in Mice Downregulates CXCR7 Associated with Defective Coronary Arteries and Cardiac Hypertrophy
Santhosh Kumar Ghadge, Moritz Messner, Herbert Seiringer, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
International Journal of Molecular Sciences
|
April 26, 2019
High Body Mass Index is Associated with Elevated Blood Levels of Progerin mRNA
Moritz Messner, Santhosh Kumar Ghadge, Thomas Schuetz, et al.
Plos One
|
April 28, 2018
Upregulation of the aging related LMNA splice variant progerin in dilated cardiomyopathy
Moritz Messner, Santhosh Kumar Ghadge, Valentina Goetsch, et al.
Aging
|
January 12, 2022
Endothelial and systemic upregulation of miR-34a-5p fine-tunes senescence in progeria
Christina Manakanatas, Santhosh Kumar Ghadge, Azra Agic, et al.
Cells
|
September 3, 2020
ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA
Moritz Messner, Santhosh Kumar Ghadge, Thomas Maurer, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
May 28, 2017
Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair
Santhosh Kumar Ghadge, Moritz Messner, Thi Van Pham, et al.
International Journal of Cardiology
|
June 23, 2009
Plasma HER2 levels are not associated with cardiac function or hypertrophy in control subjects and heart failure patients
Maximilian G Posch, Anna Panek, Andrea Kersten, et al.
Cells
|
July 12, 2024
Roxadustat Attenuates Adverse Remodeling Following Myocardial Infarction in Mice
Marc-Michael Zaruba, Simon Staggl, Santhosh Kumar Ghadge, et al.
The Lancet. Infectious Diseases
|
April 28, 2025
Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trial
Laura Wagner, Michaela Obersriebnig, Vera Kadlecek, et al.
The Lancet. Infectious Diseases
|
July 19, 2024
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial
Santhosh Kumar Ghadge, Martina Schneider, Katrin Dubischar, et al.
International Journal of Molecular Sciences
|
June 2, 2021
Smooth Muscle Specific Ablation of CXCL12 in Mice Downregulates CXCR7 Associated with Defective Coronary Arteries and Cardiac Hypertrophy
Santhosh Kumar Ghadge, Moritz Messner, Herbert Seiringer, et al.
Page
of 1